Sanofi | SNY - Interest Expense On Debt




Sanofi reported 86.78M in Interest Expense on Debt for its fiscal quarter ending in September of 2024.

Interest Expense On Debt Change Date
AbbVie USD 610M 19M Dec/2024
Amgen USD 747M 90.14B Dec/2024
AstraZeneca 429M 28M Dec/2024
Bristol-Myers Squibb USD 496M 9M Dec/2024
Canopy Growth CAD 21.28M 138K Sep/2024
Drreddys Laboratories INR 757M 159M Sep/2024
Eli Lilly USD 180.4M 35.5M Dec/2024
Galapagos EUR 50.12M 49.87M Sep/2024
Genmab DKK 2.68B 1.98B Dec/2024
GlaxoSmithKline 173M 17M Dec/2024
Glaxosmithkline 15.5M 171.25M Sep/2024
Indivior 9M 1000K Sep/2024
J&J USD 193M 77M Sep/2024
Merck USD 330M 20M Sep/2024
Novartis USD 275M 11M Dec/2024
Novartis USD 264M 18M Sep/2024
Pacira USD 4.69M 810K Sep/2024
Perrigo 42.9M 1.2M Sep/2024
Pfizer USD 739M 45M Dec/2024
Prestige Brands USD 11.37M 908K Dec/2024
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 62M 17M Dec/2024
Sanofi 86.78M 271.68M Sep/2024
Supernus Pharmaceuticals USD 0 0 Sep/2024
Zoetis USD 51M 6M Dec/2024